Lv0
0 积分 2023-10-09 加入
Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist, in Early Type 2 Diabetes
1天前
待确认
Efficacy and safety of oral orforglipron in patients with type 2 diabetes: a multicentre, randomised, dose-response, phase 2 study
1天前
已完结
Static and Dynamic Projections of Drug-Drug Interactions Caused by Cytochrome P450 3A Time-Dependent Inhibitors Measured in Human Liver Microsomes and Hepatocytes
2天前
已完结
Static and Dynamic Projections of Drug-Drug Interactions Caused by Cytochrome P450 3A Time-Dependent Inhibitors Measured in Human Liver Microsomes and Hepatocytes
5天前
已完结
The pharmacological basis for nonpeptide agonism of the GLP-1 receptor by orforglipron
7天前
已完结
Disposition and Absolute Bioavailability of Orally Administered Orforglipron in Healthy Participants
15天前
已完结
Lipogenesis and MASLD: re-thinking the role of SREBPs
15天前
已完结
Comparison of P450 Enzymes Between Cynomolgus Monkeys and Humans: P450 Identities, Protein Contents, Kinetic Parameters, and Potential for Inhibitory Profiles
27天前
已完结
Investigating organic cation transporter 1 in drug interactions: New findings from in vitro and in vivo cynomolgus monkey studies
29天前
已关闭
Interspecies Prediction of Human Drug Clearance Based on Scaling Data from One or Two Animal Species
1个月前
已完结
皖公网安备34019202002308
